Innovations in Clinical Neuroscience

Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience

VOLUME 18, ISSUE 1–3, JANUARY-MARCH 2021

Editorial Message and Issue Highlights–Vol. 18, No. 1–3, January–March 2021

Editorial Message and Issue Highlights–Vol. 18, No. 1–3, January–March 2021

Dear Colleagues: Welcome to the January–March 2021 edition of Innovations in Clinical Neuroscience (ICNS). For 2021’s first quarterly issue of ICNS, we start with two letters to the editor. In “Sexual Behavior During the COVID-19 Pandemic: It’s Telecounseling Time!” by Calabro et al, the researchers explore how Coronavirus 2019 (COVID-19) has impacted the sexual activity […]

Continue Reading

Letters to the Editor: Sexual Behavior During the COVID-19 Pandemic: It’s Telecounseling Time!

Letters to the Editor: Sexual Behavior During the COVID-19 Pandemic: It’s Telecounseling Time!

Dear Editor: COVID-19 is having a tremendous impact on the healthcare and economic systems worldwide, as well as on human behavior, negatively affecting both personal and social relationships. COVID-19 is an acute respiratory illness caused by the SARS-COV2, with transmission that occurs via droplets or direct contact with contaminated objects (i.e., fomites).1 As such, first-line […]

Continue Reading

Letters to the Editor: What About Biomarkers for Parkinson’s Disease?

Letters to the Editor: What About Biomarkers for Parkinson’s Disease?

Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in the United States; these numbers might double by 2040, as the population of older people increases.1 Diagnostic clues include the signs of resting tremor, bradykinesia, muscle rigidity, and postural imbalance. However, these clinical indicators might be inaccurate much of the time. A low rate of […]

Continue Reading

Schizophrenia

Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments

Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments

by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne C. Moore, PhD; Colin A. Depp, PhD; Emma  M. Parrish, BS; and Amy E. Pinkham, PhD Dr. Harvey is with the University of Miami Miller School of Medicine in Miami, Florida, and Research Service at Bruce W. Carter VA Medical Center in Miami, Florida. Ms. […]

Continue Reading

Role of Norepinephrine in Schizophrenia: An Old-fashioned but New Story from Emergency Medicine

Role of Norepinephrine in Schizophrenia: An Old-fashioned but New Story from Emergency Medicine

Continue Reading

The Role of Serum Lithium Concentration on Pill Burden in Psychiatric Populations

The Role of Serum Lithium Concentration on Pill Burden in Psychiatric Populations

Continue Reading

Risk Management

Risk Management: Myths and Misconceptions: Terminating Treatment

Risk Management: Myths and Misconceptions: Terminating Treatment

by  Ann L. McNary, JD Ms. McNary is a Senior Risk Manager at PRMS, Inc. FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an employee of PRMS Inc., a risk-management consulting company for health care providers. This ongoing column is dedicated to providing information to our readers on […]

Continue Reading

Risk Management: Telepsychiatry and COVID-19: Preparing for What’s Next

Risk Management: Telepsychiatry and COVID-19: Preparing for What’s Next

Continue Reading

Risk Management: Top Five HIPAA Lessons Learned: A Review of HHS Resolution Agreements

Risk Management: Top Five HIPAA Lessons Learned: A Review of HHS Resolution Agreements

Continue Reading

Recent Posts

January–March 2021 Digital Edition

January–March 2021 Digital Edition

| January 1, 2021

Click the cover below to access the January–March 2021 digital edition!

Continue Reading

Longitudinal Data in Patients with Niemann-Pick Type C Disease Under Combined High Intrathecal and Low Intravenous Dose of 2-hydroxylpropyl-β-cyclodextrin

Longitudinal Data in Patients with Niemann-Pick Type C Disease Under Combined High Intrathecal and Low Intravenous Dose of 2-hydroxylpropyl-β-cyclodextrin

| January 1, 2021

by Evangelia Bountouvi, MD, PhD; Melpomeni Giorgi, MD; Anna Papadopoulou, PhD; Kaj Blennow, PhD; Ingemar Björkhem, PhD; Maria Tsirouda, PhD; Spyridon Kanellakis, Msc, PhD; Andreas Fryganas, MD; Maria Spanou, MD; Ioanna Georgaki, MD; Sofia Asprogeraka, MD; and Argyrios Dinopoulos, PhD Drs. Bountouvi, Giorgi, Papadopoulou, Tsirouda, Fryganas, Spanou, Georgaki, Asprogeraka, and Dinopoulos are with the Third […]

Continue Reading

Catatonia in a 6-year-old Patient Following Disseminated Group A Streptococcus Infection

Catatonia in a 6-year-old Patient Following Disseminated Group A Streptococcus Infection

| January 1, 2021

by Philip B Cawkwell, MD; Ivan Daniel Mayor, BA; and Richard J. Shaw,MD Drs. Cawkwell and Shaw and Mr. Mayor are with the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, at the Stanford University School of Medicine in Palo Alto, California. FUNDING: No funding was provided for this study. DISCLOSURES: […]

Continue Reading